What are Moderna investors actually betting on?

Moderna’s stock price has continued to climb to record highs on the premise that their novel mRNA-based vaccine technology can take control of the spread of COVID-19. Since the beginning of January 2020 to the time of the writing of this article, the stock has increased by an astronomical 385 percent, based on preclinical and phase I data alone. Moderna, a vaccine-biotech company with no vaccines …

Read more…